Inseminación intrauterina en el momento actual

Alfredo Celis López

doi:10.31403/rpgo.v58i82

Autores/as

Alfredo Celis López Gineco -Obstetra, Maestro en Medicina.

DOI:

https://doi.org/10.31403/rpgo.v58i82

Resumen

La inseminación intrauterina (IIU) es la primera opción de tratamiento de la pareja infértil, en pacientes con infertilidad inexplicada, endometriosis mínima y leve, subfertilidad por factor cervical o subfertilidad por factor masculino leve. Pero su efectividad ha sido cuestionada por sus bajas tasas de éxito y los probables riesgos como el embarazo múltiple y el síndrome de hiperestimulación ovárica. A pesar de ello, sigue siendo una técnica ampliamente usada por su simplicidad y su bajo costo, lo cual le da algunas ventajas sobre la fertilización in vitro. La FIV ofrece ventajas, como obtener mayores tasas de éxito y la posibilidad de transferencia de embrión único y transferencia posterior de embriones congelados, con lo cual disminuyen los riesgos, a pesar de ser mucho más costosa. Esta revisión trata de establecer cuál es el estado de la inseminación intrauterina en el momento actual, si es que todavía sigue vigente y tiene un espacio dentro de los tratamientos de la pareja infértil o si esta en retirada a costa de la FIV.

Descargas

Los datos de descargas todavía no están disponibles.

Citas

Shields FE. Artificial insemination as related to females. Fertil Steril. 1950;1:271-80.

Sis JM. Clinical Notes on Uterine Surgery, with special reference to the Management of the Sterile Condition. London: Hardwicke, 1866.

Ivanoff EI. On the use of artificial insemination for zootechnical purposes in Rusia. J Agri Sci. 1922;12:244-56.

Hard AD. Artificial impregnation. Medical World. 1909;27:253.

Phillips EJ, Lardy HA. A yolk-buffer pabulum for the preservation of bull semen. J Dairy Sci. 1940;23:399-404

Foote RH, Bratton RW. The fertility of bovine semen in extenders containing sulfanilamide, penicillin, streptomycin, and polimyxin. J Dairy Sci. 1950;33:544-7.

Bunge A, Rand B, Sherman J. Fertilizing capacity of frozen human spermatozoa. Nature. 1953;767-70.

Steptor PC, Edwards RG. Birth after reimplantation of a human embryo. Lancet. 1978;12:2(8085):366.

Keck C, Gerber-Schafer C, Breckwoldt M. Intrauterine insemination as first line treatment of unexplained and male factor infertility. Eur J Obstet Gynecol Reprod Biol. 1998;79:193-7.

Guzick DS, Carson SA, Coutifares C, Overstreet JW, Factor- Litvak P, et al. Efficacy of superovulation and intrauterine insemination in the treatment of infertility. National cooperative Reproductive Medicine Network. N Engl J Med. 1999;340:177-83.

Devroey P, Liu J, Nagy Z, Goossens A, Tournaye H, et al. Pregnancies after testicular sperm extraction and intracytoplasmc sperm injection in non-obstructive azoospermia. Hum Reprod. 1995;10:1457-60.

ESHRE Capri workshop Group. Intrauterine insemination. Hum Reprod Update. 2009;15:255-67.

Levene MI, Wild J, Steer P. Higher multiple birth and the modern management of infertility in Britain. The British Association of Perinatal Medicine. Br J Obstet Gynecol. 1992;99(7):607-13.

Verhulst SM, Cohlen BJ, Hughes E, te Velde E, Heineman MJ. Intra-uterine insemination for unexplained subfertility. Cochrane Database Syst Rev. 2006;Art No: CD001838.

Crosignani PG, Walters DE, Soliani A. The ESHRE multicentre trial on the treatment of unexplained infertility: a preliminar report. Hum Reprod. 1991;6:953-8.

Crosignani PG, Walters DE. Clinical pregnancy and male subfertility: the ESHRE multicentre trial on the treatment of male subfertility. Hum Reprod. 1994;9:1112-8.

Remohi J, Gastaldi C, Patrizio P, Gerli S, Ord T, Asch RH, Balmaceda JP. Intrauterine insemination and controlled ovarian hyperestimulation in cycles before GIFT. Human Reprod. 1989;4:918-20.

Lalich RA, Marut EL, Prins GS, Scommegna A. Life table analysis of intrauterine insemination pregnancy rates. Am J Obstet Gynecol. 1988;158:980-4.

Dickey RP, Taylos SN, Lu PY, Sartor BM, Rye PH, Pyrzak R. Effect of diagnosis, age, sperm quality, and number of preovulatory follicles on the outcome of multiple cycles of clomiphene citrate-intauterine insemination. Fertil Steril. 2002;78;1088-95.

Csapo AI, Pulkkinem M. Indispensability of the human corpus luteum in the maintenance of early pregnancy. Luteectomy evidence. Obstet Gynecol Surv. 1978;33:69-81.

Baird Dt. Mode of action of medical methods of abortion. J An Med Women’s Assoc. 2000;55(Suppl 3):121-6.

Diluigi AJ, Nulsen JC. Effects of gonadotropin-releasing hormone agonist and antagonist on luteal function. Curr Opin Obstet Gynecol. 2007;19:258-65.

Abu-Heija AT, Fleming R, Yates RWW, Coutts JR. Pregnancy outcome following exposure to gonadotrophin-releasing hormone analogue during early pregnancy: comparisons in patients with normal or elevated luteinizing hormone. Hum Reprod. 1995;10:3317-9.

Tarlatzis BC, Fauser BC, Kolibianakis EM, Diedrich K, Rombauts L, Devroey P. GnRH antagonists in ovarian stimulation for IVF. Hum Reprod Update. 2006;12:333-40.

Macklon NS, Fauser BC. Impact of ovarian hyperestimulation on the luteal phase. J Reprod Fertil. 2000;55(Suppl 1):101-8.

Kolibianakis EM, Bourgain C, Platteau P, Albano C, Van Steirteghem AC, Devroey P. Abnormal endometrial development occurs during the luteal phase of nonsupplemental donor cycle treated with recombinant folliclestimulating hormone and gonadotrophin-releasing hormone antagonists. Fertil Steril. 2003;80:464-6.

Ragni G, Vegetti W, Baroni E, Colombo M, Arnoldi M, Lombroso G, Crosignani PG. Comparison of luteal phase profile in gonadotrophin stimulated cycles with or without a gonadotrophin-releasing hormone antagonist. Hum Reprod. 2001;16:2258-62.

Van Voorthis BJ, Sparks AE, Allen BD, Stovall DW, Syrop CH, Chapler FK. Cost-effectiveness of infertility treatments: a cohort study. Fertil Steril. 1997;67:830-6.

Van Voorthis BJ, Barnett M, Sparks AE, Syrop CH, Rosenthal G, Dawson J. Effect of the total motile sperm count on the efficacy and cost-effectiveness of intrauterine insemination and in vitro fertilization. Fertil Steril. 2001;75:661-8.

Philips Z, Barraza-Llorens, Posnett J. Evaluation of the relative cost-efectiveness of treatments for infertility in the UK. Hum Reprod. 2000;15:95-106.

Reindollar RH, Regan MM, Neumann PJ , Levine BS, Thornton KL, Alper MM, Goldman MB. A randomized clinical trial to evaluate optimal treatment for unexplained infertility : the fast track and standard treatment (FASTT trial). Fertil Steril. 2010;94(3):888-99.

de Mouzon J, Goossens V, Bhattacharya S, Castilla JA, et al; The European IVF Monitoring Programme (EIM), for the European Society of Human Reproduction and Embriology (ESHRE). Assisted reproductive technology and intrauterine insemination in Europe, 2006: results generated from European registers by ESHRE. Hum Reprod. 2010;25(8):1851-62.

Verberg MF, Macklon NS, Nargund G, Frydman R, Devroey P, Broekmans FJ, Fauser BC. Mild ovarian stimulation for IVF. Hum Reprod Update. 2009;15:13-29.

Pelinck MJ, Hock A, Simons AH, Heineman MJ. Efficacy of natural cycle IVF: a review of the literature. Hum Reprod Update. 2002;8:129-39.

Custers IM, Steures P, Hompes P, Flierman P, van Kasteren Y, van Dop PA, van der Veen F, Mol BW. Intrauterine insemination: how many cycles should we perform? Hum Reprod. 2008;23:885-8.

ESHRE Capri Workshop Group. Diagnosis and management of the infertile couple: missing information. Hum Reprod Update. 2004;10:295-307.

ESHRE Capri Workshop Group. Intracytoplasmic sperm injection (ICSI) in 2006: evidence and evolution. Hum Reprod Update. 2004;13:515-26.